Published in Isr Med Assoc J on October 01, 2014
Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev (2016) 0.79
Systemically Administered, Target Organ-Specific Therapies for Regenerative Medicine. Int J Mol Sci (2015) 0.76
Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins. Biomedicines (2017) 0.75
Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells. Nat Chem Biol (2017) 0.75
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis (2002) 20.48
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum (1993) 7.14
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum (1996) 6.88
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
The product of a newly identified gene, gInF, is required for synthesis of glutamine synthetase in Salmonella. Proc Natl Acad Sci U S A (1977) 5.19
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Nitrogen control in Salmonella: regulation by the glnR and glnF gene products. Proc Natl Acad Sci U S A (1979) 4.79
Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol (1996) 4.45
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Association between polyarteritis and Australia antigen. Lancet (1970) 4.32
Improvement of retardates' mealtime behaviors by timeout procedures using multiple baseline techniques. J Appl Behav Anal (1970) 3.97
Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis (1996) 3.68
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science (1991) 3.56
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
A simple method for the detection of Chlamydia trachomatis infections in general practice. J R Coll Gen Pract (1987) 3.08
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med (1991) 3.04
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1993) 2.88
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 2.61
Searching for autolysin functions. Characterization of a pneumococcal mutant deleted in the lytA gene. Eur J Biochem (1986) 2.58
The training and generalization of a conversational speech form in nonverbal retardates. J Appl Behav Anal (1974) 2.55
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol (1992) 2.50
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Coronary artery anomalies: a review of more than 10,000 patients from the Clayton Cardiovascular Laboratories. Tex Heart Inst J (1988) 2.48
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol (1992) 2.43
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis (2010) 2.38
Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol (1998) 2.22
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19
Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem (2005) 2.14
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet (1998) 2.06
The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis (1994) 2.03
Misdiagnosis in fibromyalgia: a multicentre study. Clin Exp Rheumatol (2012) 2.02
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum (2012) 1.96
Assessment of disease severity and prognosis. Clin Exp Rheumatol (2003) 1.86
Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J Biol Chem (1998) 1.83
Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus (1998) 1.79
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol (1999) 1.68
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol (2001) 1.63
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology (Oxford) (2002) 1.61
A comparison of ultrasonography and magnetic resonance imaging in the evaluation of temporomandibular joint involvement in rheumatoid arthritis and psoriatic arthritis. Rheumatology (Oxford) (2003) 1.61
The clinical syndrome of atrial myxoma. JAMA (1974) 1.60
Early systolic closure of the aortic valve in patients with hypertrophic subaortic stenosis and discrete subaortic stenosis. Correlation with preoperative and postoperative hemodynamics. Am J Cardiol (1978) 1.60
Lack of specificity of endoglin expression for tumor blood vessels. Int J Cancer (2001) 1.60
Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin (2010) 1.59
[Nasogastric tube: intratracheal malposition and entrapment in a bronchial suture]. Ann Fr Anesth Reanim (1998) 1.59
An integrated metric physical map of human chromosome 19. Nat Genet (1995) 1.54
The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction. Eur Heart J (2001) 1.54
Chronic eosinophilic pneumonia as a presenting feature of Churg-Strauss syndrome. Eur Respir J (1994) 1.53
An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene (1997) 1.50
Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol (1998) 1.50
Prevalence of anticardiolipin antibodies in coronary artery disease. Am J Cardiol (1990) 1.49
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum (1991) 1.49
Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis (2005) 1.48
Shrinking lung in primary Sjögren's syndrome. Arthritis Rheum (1999) 1.47
Aortocoronary saphenous vein bypass. Results in 1,492 patients, with particular reference to patients with complicating features. Ann Thorac Surg (1973) 1.47
Ultrasonographic and functional changes of the ulnar nerve at Guyon's canal after carpal tunnel release. Clin Neurophysiol (2009) 1.46
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res (1996) 1.45
Improving feasibility of posterior descending coronary artery flow recording by transthoracic Doppler echocardiography. Eur J Echocardiogr (2003) 1.45
Anti-Sm and anti-RNP antibodies. Autoimmunity (2005) 1.43
Support of 1H NMR assignments in proteins by biosynthetically directed fractional 13C-labeling. J Biomol NMR (1992) 1.42
Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol (2007) 1.41
Risk factors associated with preterm delivery after fetoscopic laser ablation for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol (2014) 1.40
Vasculitis in association with Australia antigen. J Exp Med (1971) 1.40
Emergency coronary stenting for acute occlusive dissection of the left main coronary artery. Cathet Cardiovasc Diagn (1993) 1.39
Predictors of short term clinical and angiographic outcome after coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn (1995) 1.39
FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J Immunol (2000) 1.39
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation (1996) 1.39
APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol (1999) 1.38
Sevoflurane analgesia in obstetrics: a pilot study. Int J Obstet Anesth (2003) 1.38
Neuropsychiatric questionnaires in systemic lupus erythematosus. Clin Exp Rheumatol (2014) 1.38
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis (2003) 1.32
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood (1993) 1.29
Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthritis Cartilage (2003) 1.29
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
The product of the nitrogen fixation regulatory gene nfrX of Azotobacter vinelandii is functionally and structurally homologous to the uridylyltransferase encoded by glnD in enteric bacteria. J Bacteriol (1991) 1.28
Precise vicinal coupling constants 3JHN alpha in proteins from nonlinear fits of J-modulated [15N,1H]-COSY experiments. J Biomol NMR (1992) 1.28
Autoantibodies specific for alpha-enolase in systemic autoimmune disorders. J Rheumatol (2000) 1.27
Cystamine induces toxicity in hepatocytes through the elevation of cytosolic Ca2+ and the stimulation of a nonlysosomal proteolytic system. J Biol Chem (1986) 1.25
Immobilization and single-step purification of fusion proteins using DEAE-cellulose. Eur J Biochem (1992) 1.22
Cascade control of Escherichia coli glutamine synthetase. Purification and properties of PII uridylyltransferase and uridylyl-removing enzyme. J Biol Chem (1983) 1.22
Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease. Clin Exp Rheumatol (2010) 1.21
Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice. Cancer Res (2001) 1.21